Phase Ib/IIa, Single-Centre, Placebo-Controlled Randomized Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection

Trial Profile

Phase Ib/IIa, Single-Centre, Placebo-Controlled Randomized Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection

Completed
Phase of Trial: Phase I/II

Latest Information Update: 07 Jul 2015

At a glance

  • Drugs Elsulfavirine (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Sponsors Viriom
  • Most Recent Events

    • 15 Nov 2013 New trial record
    • 08 Oct 2013 Positive interim results will be presented at the 15th Annual International Meeting of the Institute of Human Virology according to a Viriom media release. Results were also reported in the media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top